ClinicalTrials.gg
RecruitingNCT07943442MRF MNDUpdated Nov 17, 2026

Novel MRI for an Earlier Diagnosis of Motor Neurone Disease

An observational study in Motor Neurone Disease (MND) and Health Adult Subjects, sponsored by The Leeds Teaching Hospitals NHS Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by The Leeds Teaching Hospitals NHS Trust · Observational

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 70 studies in Amyotrophic Lateral Sclerosis with a site in United Kingdom — 15 open to participants now, 22 under way, 6 of them phase 3. Amyotrophic Lateral Sclerosis · United Kingdom.

Planned enrollment
10th of 15
20 · median 73
Started
2026
with 6 others
Observational
15 of 70
8 open now
Primary completion
2027-05
later than 13 of 21 live
Registered
70th of 70
by date

Among the 70 studies in Amyotrophic Lateral Sclerosis with a site in United Kingdom, this one is the 10th largest by planned enrollment of the 15 observational ones that give a count, is one of 7 that started in 2026, is one of 15 observational ones, reaches primary completion later than 13 of the 21 other live ones, and was the 70th registered.

Amyotrophic Lateral Sclerosis

980 studies on the registry are indexed under Amyotrophic Lateral Sclerosis; 279 are open to participants now.

Browse Amyotrophic Lateral Sclerosis studies →

Open to participants now

15 of the 70 studies in Amyotrophic Lateral Sclerosis with a site in United Kingdom are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 193 Amyotrophic Lateral Sclerosis studies recruiting now, 118 (61%) set no upper age limit and 23 (12%) stop at 75 or younger; 15 take children under 18; 55 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Amyotrophic Lateral Sclerosis with a site in United Kingdom, or all of them as a file.
02

Study summary

The goal of the study is Can MR Fingerprinting identify quantitative differences in brains of patients with MND and age-matched healthy controls?

Read the detailed description

The Investigators will recruit consecutive patients with MND, identified via the Leeds MND clinic.

Patients will be provided with a patient information sheet (PIS) when they attend the clinic and will have the opportunity to discuss the study with a clinician and ask questions.

If they are willing and able to provide informed consent at this time, consent will be taken, and the participant will be reassured they may withdraw at any time. If the patient wishes time to consider the study, with their permission, they will be contacted via telephone after 24 hours and asked whether or not they wish to be included, again reassured they may withdraw at any time.

An email inviting individuals aged 18 or over to undergo MR imaging of the brain will be distributed throughout Leeds Teaching Hospitals Trust. Those interested will be asked to send their contact details via e-mail reply to the Department of Neuroradiology.

Potential participants will be contacted by a member of the research team and will be taken through a pre-prepared questionnaire detailing present and past medical history. Individuals that answer negatively for the presence of chronic or current illness, particularly regarding neurological disease or psychiatric conditions and that are free from medication and that satisfy MR safety regulations (i.e. no cardiac pacemakers or metallic implants) will be provided with an MRI appointment. All participants will be sent (via email and at least 24 hours prior to the MRI appointment) a PIS. Informed consent will be obtained on arrival for their MRI appointment by a member of the research team.

A consultant neuroradiologist will review all imaging for both cohorts. Any incidental pathology discovered on the MRI requiring medical review will be recorded as a 'Foreign Films for Opinion' on the the Leeds Teaching Hospitals Trust radiology information system and will be alerted to the volunteers' GP, reflecting pre-existing practice within Leeds Teaching Hospitals Trust for research imaging studies.

03

Conditions studied

  • Motor Neurone Disease (MND)
  • Health Adult Subjects

Keywords

  • Motor Neurone Disease
  • MRI
  • MR Fingerprinting
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The target population will be patients with MND attending the MND clinic, Leeds Teaching Hospitals Trust and healthy volunteers of workers or relatives of workers within Leeds Teaching Hospitals Trust.

Although MND (ALS) can strike at any age, symptoms most commonly develop between the ages of 55 and 75. Men are slightly more likely to develop ALS than women. However, at older ages, men and women are equally likely to be diagnosed with ALS. Whites and non-Hispanics are most likely to develop the disease, but ALS affects people of all races and ethnic backgrounds.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥18yrs
  • Able and willing to provide consent
  • Able to communicate with staff and safely comply with the study procedures

Additional inclusion criteria for MND participants:

  • ALS patients with definite or probable motor neuron disease based on the Awaji criteria

Additional inclusion criteria for healthy volunteers:

  • Free from chronic or current illness particularly:
  • Neurological disorders including migraines
  • Psychiatric disorders
  • Prior head injury resulting in brain damage
  • Prior neurosurgical or neurovascular intervention
  • Free from taking medication
  • Non-drug and non-alcohol abuse
  • Non-smoker

Exclusion criteria

Exclusion criteria all participants:

  • to MRI, including:

    • non-MRI compatible medical devices and implants
    • in patients with previous penetrating trauma to the eye, or patients at high risk of previous metal foreign body injury to the eye (e.g. welding), skull x-ray will be performed; these patients may be included in the absence of residual metal fragments on x-ray
    • Inability to lie flat in the MRI scanner
    • ALS patients in an advanced disease stage (ALSFRS-R \< 25) with respiratory insufficiency (forced vital capacity (FVC) \< 60%), on non-invasive ventilation or receiving percutaneous gastrostomy feeding.
  • Pregnant
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Groups and cohorts

  • MND Patients

    MND

    Radiation: MRI

  • Healthy Volunteers

    Healthy volunteers of workers or relatives of workers within Leeds Teaching Hospitals Trust

    Radiation: MRI

Interventions

  • RadiationMRI

    MRI of the brain including MRF

06

What researchers measure

Primary outcomes

  1. Quantitative values of brain cortical regions on MRF

    Both cohorts will undergo the same MRI protocol comprising routine clinical structural imaging of the brain and MRF; with a scan time of less than 60 minutes. All images from both cohorts will be reviewed by a consultant neuroradiologist. Should there be any unexpected findings, the volunteers' GP will be informed in writing. After the scan, the volunteers from both cohorts will be free to leave, at which point their direct participation in the study will concluded.

    Time frame: Scan time of less than 60 minutes

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for May 2027, 7 months after the start.

Of 128 non-industry observational studies under Amyotrophic Lateral Sclerosis, half reached primary completion within 67 months of starting (the median), counting those still running; a quarter within 30 and three quarters within 125. This study's planned 7 months is below that.

Counting every sponsor, half of 137 studies reached it within 64 months; a quarter within 29 and three quarters within 114.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2026
First posted
Nov 17, 2026
StartActual
Oct 20, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
May 31, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07943442
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Oct 20, 2026
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Stuart Currie
Contact
stuartcurrie@nhs.net
+44 01133923180
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion